Q3's Top 10 Deals Led By J&J's $42B Tylenol Owner Spinoff
The largest deal of the third quarter came by way of Johnson & Johnson's August split-off of Kenvue Inc., which valued the roughly 80% stake in the consumer health company at $42.2...To view the full article, register now.
Already a subscriber? Click here to view full article